Free Trial

Citigroup Initiates Coverage on Genpact (NYSE:G)

Genpact logo with Computer and Technology background

Key Points

  • Citigroup has initiated coverage on Genpact (NYSE:G), assigning a "neutral" rating with a price target of $43.00, indicating a potential upside of 8.19% from the current stock price.
  • Other analysts have offered mixed ratings on Genpact, with three rating it as a buy, while six issued a hold rating, establishing a consensus rating of "Hold" with an average target price of $51.13.
  • Genpact's stock recently traded down 1.4% to $39.75, following the announcement of a quarterly earnings report that beat consensus estimates with an EPS of $0.88.
  • Five stocks to consider instead of Genpact.

Investment analysts at Citigroup started coverage on shares of Genpact (NYSE:G - Get Free Report) in a report issued on Wednesday,Benzinga reports. The firm set a "neutral" rating and a $43.00 price target on the business services provider's stock. Citigroup's target price would suggest a potential upside of 8.19% from the company's current price.

Other research analysts have also recently issued research reports about the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Genpact in a report on Thursday, July 17th. They set a "hold" rating and a $47.00 price target for the company. Wall Street Zen cut shares of Genpact from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Needham & Company LLC boosted their price target on shares of Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Mizuho boosted their price target on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a report on Tuesday, July 1st. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Genpact in a report on Wednesday, October 8th. Three analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $51.13.

Read Our Latest Stock Report on G

Genpact Stock Down 1.4%

Shares of G stock traded down $0.55 during trading on Wednesday, reaching $39.75. The company's stock had a trading volume of 1,961,910 shares, compared to its average volume of 1,654,497. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53. The company has a market capitalization of $6.93 billion, a price-to-earnings ratio of 13.20, a P/E/G ratio of 1.37 and a beta of 0.89. The stock's 50-day moving average price is $42.54 and its 200 day moving average price is $44.06. Genpact has a 1-year low of $37.82 and a 1-year high of $56.76.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The firm had revenue of $1.25 billion during the quarter, compared to analysts' expectations of $1.23 billion. During the same quarter in the previous year, the business posted $0.79 earnings per share. The business's quarterly revenue was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, research analysts anticipate that Genpact will post 3.21 EPS for the current year.

Insider Activity at Genpact

In related news, CEO Balkrishan Kalra sold 55,000 shares of the company's stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total value of $2,384,800.00. Following the completion of the sale, the chief executive officer owned 295,246 shares in the company, valued at $12,801,866.56. This represents a 15.70% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Piyush Mehta sold 76,902 shares of the company's stock in a transaction on Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the completion of the sale, the senior vice president owned 134,880 shares of the company's stock, valued at approximately $5,743,190.40. This trade represents a 36.31% decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by insiders.

Institutional Trading of Genpact

Institutional investors and hedge funds have recently bought and sold shares of the business. Cornerstone Planning Group LLC purchased a new stake in Genpact in the 1st quarter valued at $27,000. Private Trust Co. NA raised its position in Genpact by 364.2% in the 3rd quarter. Private Trust Co. NA now owns 636 shares of the business services provider's stock valued at $27,000 after purchasing an additional 499 shares during the last quarter. Richardson Financial Services Inc. purchased a new stake in Genpact in the 1st quarter valued at $35,000. SVB Wealth LLC purchased a new stake in Genpact in the 1st quarter valued at $41,000. Finally, Steph & Co. purchased a new position in Genpact during the 2nd quarter worth $37,000. Hedge funds and other institutional investors own 96.03% of the company's stock.

About Genpact

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Analyst Recommendations for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Markets Are Sliding: Where to Find Opportunity

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines